Loading...
Loading...
SMTI| Name | Value |
|---|---|
| Revenues | 20.2M |
| Cost of Revenue | 3.1M |
| Gross Profit | 17.0M |
| Operating Expense | 19.9M |
| Operating I/L | -2.9M |
| Other Income/Expense | -0.6M |
| Interest Income | 0.0M |
| Pretax | -3.5M |
| Income Tax Expense | -0.0M |
| Net Income/Loss | -3.5M |
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to healthcare facilities in the United States. Its product line includes surgical activated collagen powder and gel, antimicrobial skin and wound cleanser, hydrolyzed collagen powder and gel, small intestinal submucosa extracellular matrix sheet, amnion matrix, and other advanced wound care devices. These products are used in various surgical specialties and wound management, catering to physicians, hospitals, clinics, and post-acute care settings.
